GB9813646D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9813646D0
GB9813646D0 GBGB9813646.8A GB9813646A GB9813646D0 GB 9813646 D0 GB9813646 D0 GB 9813646D0 GB 9813646 A GB9813646 A GB 9813646A GB 9813646 D0 GB9813646 D0 GB 9813646D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9813646.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Priority to GBGB9813646.8A priority Critical patent/GB9813646D0/en
Publication of GB9813646D0 publication Critical patent/GB9813646D0/en
Priority to BRPI9907647-0A priority patent/BR9907647B1/en
Priority to KR1020007008399A priority patent/KR100669174B1/en
Priority to AU27226/99A priority patent/AU753519B2/en
Priority to CNB998036722A priority patent/CN100396276C/en
Priority to TW088101639A priority patent/TW457095B/en
Priority to CNA2004100058263A priority patent/CN1623543A/en
Priority to RU2003115501/15A priority patent/RU2268045C2/en
Priority to CZ20002834A priority patent/CZ303168B6/en
Priority to MYPI99000384A priority patent/MY125921A/en
Priority to DE69940904T priority patent/DE69940904D1/en
Priority to ES99907491T priority patent/ES2324378T3/en
Priority to EP99907491A priority patent/EP1052974B1/en
Priority to NZ506389A priority patent/NZ506389A/en
Priority to SI9931034T priority patent/SI1052974T1/en
Priority to PT99907491T priority patent/PT1052974E/en
Priority to IL13755099A priority patent/IL137550A0/en
Priority to PCT/EP1999/000702 priority patent/WO1999039694A2/en
Priority to CA002320182A priority patent/CA2320182C/en
Priority to ARP990100446A priority patent/AR017979A1/en
Priority to AT99907491T priority patent/ATE431733T1/en
Priority to TR2000/02299T priority patent/TR200002299T2/en
Priority to JP2000530194A priority patent/JP4644364B2/en
Priority to MXPA00007681A priority patent/MXPA00007681A/en
Priority to KR1020057022710A priority patent/KR20060002022A/en
Priority to SK5020-2009A priority patent/SK287487B6/en
Priority to HU0101564A priority patent/HUP0101564A3/en
Priority to IDW20001472A priority patent/ID26549A/en
Priority to KR1020087003239A priority patent/KR20080016756A/en
Priority to PL342629A priority patent/PL201329B1/en
Priority to PL381163A priority patent/PL201335B1/en
Priority to SK1170-2000A priority patent/SK287775B6/en
Priority to DK99907491T priority patent/DK1052974T3/en
Priority to RU2000123171/14A priority patent/RU2214246C2/en
Priority to CO99006429D priority patent/CO4920246A1/en
Priority to PE1999000092A priority patent/PE20000272A1/en
Priority to IT1999MI000208A priority patent/IT1313549B1/en
Priority to BE9900077A priority patent/BE1012140A3/en
Priority to FR9901356A priority patent/FR2774909B1/en
Priority to IL137550A priority patent/IL137550A/en
Priority to NO20003930A priority patent/NO329376B1/en
Priority to HK01103518.6A priority patent/HK1033809A1/en
Priority to US10/410,376 priority patent/US20030203876A1/en
Priority to CL200302786A priority patent/CL2003002786A1/en
Priority to US11/343,827 priority patent/US20060127423A1/en
Priority to US11/598,506 priority patent/US20070060627A1/en
Priority to US12/123,639 priority patent/US20080221065A1/en
Priority to CY20091100866T priority patent/CY1109311T1/en
Priority to JP2009278624A priority patent/JP2010090147A/en
Priority to NO20100302A priority patent/NO20100302L/en
Priority to US13/020,907 priority patent/US20110124691A1/en
Ceased legal-status Critical Current

Links

GBGB9813646.8A 1998-02-05 1998-06-24 Organic compounds Ceased GB9813646D0 (en)

Priority Applications (51)

Application Number Priority Date Filing Date Title
GBGB9813646.8A GB9813646D0 (en) 1998-06-24 1998-06-24 Organic compounds
BRPI9907647-0A BR9907647B1 (en) 1998-02-05 1999-02-03 Pharmaceutical formulation in the form of a concentrate for infusion, which should be diluted prior to administration, and solution for infusion.
KR1020007008399A KR100669174B1 (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
AU27226/99A AU753519B2 (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
CNB998036722A CN100396276C (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
TW088101639A TW457095B (en) 1998-02-05 1999-02-03 Pharmaceutical formulations comprising epothilones and lyophilised compositions comprising epothilones
CNA2004100058263A CN1623543A (en) 1998-02-05 1999-02-03 Organic compounds
RU2003115501/15A RU2268045C2 (en) 1998-06-24 1999-02-03 Lyophilized composition
CZ20002834A CZ303168B6 (en) 1998-02-05 1999-02-03 Pharmaceutical composition
MYPI99000384A MY125921A (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
DE69940904T DE69940904D1 (en) 1998-02-05 1999-02-03 PHARMACEUTICAL COMPOSITION CONTAINING EPOTHILONE
ES99907491T ES2324378T3 (en) 1998-02-05 1999-02-03 PHARMACEUTICAL COMPOSITION CONTAINING EPOTILONE.
EP99907491A EP1052974B1 (en) 1998-02-05 1999-02-03 Pharmaceutical formulation containing epothilone
NZ506389A NZ506389A (en) 1998-02-05 1999-02-03 Pharmaceutical compositions containing epothilone which can be optionally lyophilised
SI9931034T SI1052974T1 (en) 1998-02-05 1999-02-03 Pharmaceutical formulation containing epothilone
PT99907491T PT1052974E (en) 1998-02-05 1999-02-03 Pharmaceutical formulation containing epothilone
IL13755099A IL137550A0 (en) 1998-02-05 1999-02-03 Epothilone compositions
PCT/EP1999/000702 WO1999039694A2 (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
CA002320182A CA2320182C (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
ARP990100446A AR017979A1 (en) 1998-02-05 1999-02-03 PHARMACEUTICAL FORMULATIONS OF EPOTILONES, METHOD FOR THE PREPARATION AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AT99907491T ATE431733T1 (en) 1998-02-05 1999-02-03 PHARMACEUTICAL COMPOSITION CONTAINING EPOTHILONES
TR2000/02299T TR200002299T2 (en) 1998-02-05 1999-02-03 Epothilon compositions.
JP2000530194A JP4644364B2 (en) 1998-02-05 1999-02-03 Epothilone composition
MXPA00007681A MXPA00007681A (en) 1998-02-05 1999-02-03 Compositions containing organic compounds.
KR1020057022710A KR20060002022A (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
SK5020-2009A SK287487B6 (en) 1998-02-05 1999-02-03 Lyophilised formulation and reconstituted lyophilised formulation
HU0101564A HUP0101564A3 (en) 1998-02-05 1999-02-03 Compositions containing epothilone
IDW20001472A ID26549A (en) 1998-02-05 1999-02-03 EPOTILON COMPOSITIONS
KR1020087003239A KR20080016756A (en) 1998-02-05 1999-02-03 Compositions containing organic compounds
PL342629A PL201329B1 (en) 1998-02-05 1999-02-03 Organic compounds containing compositions
PL381163A PL201335B1 (en) 1998-06-24 1999-02-03 Lyophilized composition and application of lyophilized composition
SK1170-2000A SK287775B6 (en) 1998-02-05 1999-02-03 Pharmaceutical formulation containing epothilone, infusion solution and use of pharmaceutical formulation
DK99907491T DK1052974T3 (en) 1998-02-05 1999-02-03 Pharmaceutical composition containing epothilone
RU2000123171/14A RU2214246C2 (en) 1998-02-05 1999-02-03 Epothilone-containing compositions
CO99006429D CO4920246A1 (en) 1998-02-05 1999-02-04 FREEZE COMPOSITION COMPRISING EPOTILONE A AND B WITH MANITOL OR CYCLODEXTRIN.
PE1999000092A PE20000272A1 (en) 1998-02-05 1999-02-04 PHARMACEUTICAL FORMULATIONS OF EPOTILONES
IT1999MI000208A IT1313549B1 (en) 1998-02-05 1999-02-04 HEPOTYLONE-BASED PHARMACEUTICAL FORMULATIONS 3
BE9900077A BE1012140A3 (en) 1998-02-05 1999-02-04 Organic compounds.
FR9901356A FR2774909B1 (en) 1998-02-05 1999-02-05 PHARMACEUTICAL FORMULATION, PERFUSION SOLUTION AND LYOPHILIZED COMPOSITION COMPRISING AN EPOTHILONE.
IL137550A IL137550A (en) 1998-02-05 2000-07-27 Epothilone compositions
NO20003930A NO329376B1 (en) 1998-02-05 2000-08-03 Pharmaceutical formulations containing organic compounds and their use
HK01103518.6A HK1033809A1 (en) 1998-02-05 2001-05-22 Pharmaceutical formulation containing epothilone
US10/410,376 US20030203876A1 (en) 1998-02-05 2003-04-09 Organic compounds
CL200302786A CL2003002786A1 (en) 1998-02-05 2003-12-30 LIOFILIZED COMPOSITION THAT INCLUDES I) AN EPOTILONE AND II) MANITOL OR A CYCLODEXTRINE AND LIOFILIZED COMPOSITION THAT INCLUDES THEM RECONSTITUTED WITH SOLVENT, USED AS A CYTOTOXIC IN TUMOR TREATMENT.
US11/343,827 US20060127423A1 (en) 1998-02-05 2006-01-31 Organic compounds
US11/598,506 US20070060627A1 (en) 1998-02-05 2006-11-13 Organic compounds
US12/123,639 US20080221065A1 (en) 1998-02-05 2008-05-20 Organic compounds
CY20091100866T CY1109311T1 (en) 1998-02-05 2009-08-12 PHARMACEUTICAL FORM THAT INCLUDES
JP2009278624A JP2010090147A (en) 1998-02-05 2009-12-08 Epothilone composition
NO20100302A NO20100302L (en) 1998-02-05 2010-03-04 Compositions containing organic compounds
US13/020,907 US20110124691A1 (en) 1998-02-05 2011-02-04 Organic Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9813646.8A GB9813646D0 (en) 1998-06-24 1998-06-24 Organic compounds

Publications (1)

Publication Number Publication Date
GB9813646D0 true GB9813646D0 (en) 1998-08-26

Family

ID=10834315

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9813646.8A Ceased GB9813646D0 (en) 1998-02-05 1998-06-24 Organic compounds

Country Status (3)

Country Link
GB (1) GB9813646D0 (en)
PL (1) PL201335B1 (en)
RU (1) RU2268045C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017009289A (en) * 2015-01-14 2017-10-11 Chiesi Farm Spa Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same.

Also Published As

Publication number Publication date
RU2268045C2 (en) 2006-01-20
PL201335B1 (en) 2009-03-31

Similar Documents

Publication Publication Date Title
GB9807779D0 (en) Organic compounds
GB9802251D0 (en) Organic compounds
GB9802725D0 (en) Organic compounds
GB9802249D0 (en) Organic compounds
GB9804265D0 (en) Organic compounds
GB9802355D0 (en) Organic compounds
GB9813646D0 (en) Organic compounds
GB9804849D0 (en) Organic compounds
GB9810245D0 (en) Organic compounds
GB9809939D0 (en) Organic compounds
GB9809296D0 (en) Organic compounds
GB9809295D0 (en) Organic compounds
GB9808167D0 (en) Organic compounds
GB9809941D0 (en) Organic compounds
GB9807628D0 (en) Organic compounds
GB9806414D0 (en) Organic compounds
GB9806413D0 (en) Organic compounds
GB9806290D0 (en) Organic compounds
GB9810243D0 (en) Organic compounds
GB9805936D0 (en) Organic compounds
GB9805796D0 (en) Organic compounds
GB9805199D0 (en) Organic compounds
GB9805104D0 (en) Organic compounds
GB9804850D0 (en) Organic compounds
GB9805937D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)